Home  |  Profile  |  Mission  |  Organisation  |  e-CRF  |  Technology 

Italiano





AIRTEL
e-CRF

Esperienze

Clinical Trial: Pegasys Randomized Evaluation Triple Therapy Yearly (Pretty Study)
N° Sites: 20
N° Patients: 300
Trial Design: Phase IIIB

Clinical Trial: Efficacy and safety of peg-interferon alfa-2a therapy alone or in combination with Ribavirin in cirrhosis-related OLT patients
N° Sites: 12
N° Patients: 46
Trial Design: Phase IIIB

Clinical Trial: Real Life Paclitaxel Registry
N° Sites: 6
N° Patients: 1071
Trial Design: Observational multicentric registry.

Clinical Trial: Italian Minivision registry in small vessels (Risico Study)
N° Sites: 25
N° Patients: 143
Trial Design: Observational multicentric registry.

Clinical Trial: Pegylated Interferons and Real Optimization of Best Efficacy (Probe Project)
N° Sites: 164
N° Patients: 10840
Trial Design: Observational multicentric retrospective and prospectic

Clinical Trial: Italian questionnaire on Severe Episodic Pain (Dolepi Study)
N° Sites: 10
N° Patients: 540
Trial Design: Observational multicentric registry. di validazione.

Clinical Trial: Chronic HBsAg carrier profiling in Italy
N° Sites: 21
N° Patients: 1415
Trial Design: Epidemiologic, multicentric, institutional (Istituto Superiore di Sanità)

Clinical Trial: Optimized Pegylated Interferons Efficacy & anti-retroviral approach (Opera Project)
N° Sites: 102
N° Patients: 1560
Trial Design: Observational multicentric prospectic

Clinical Trial: Efficacy and failure of therapeutic pattern with Tenofir (Gnomo study)
N° Sites: 31
N° Patients: 1224
Trial Design: Observational with genomic analysis

Clinical Trial: Peginterferon and Adefovir, in Patients with Chronic Hepatitis B (Peg-For-B Study)
N° Sites: 9
N° Patients: 80
Trial Design: Phase IIIB

Clinical Trial: Pegasys On Wedge End-point in non-Responders (Power Study)
N° Sites: 7
N° Patients: 41
Trial Design: Phase IIIB

Clinical Trial: Data gathering during use of Cinacalcet out of clinic sperimentation, in dialysised-patients affected by Secondary Hyperparathiroidism in according to D.M. 8 May 2003
N° Sites: 30
N° Patients: 350
Trial Design: Compassionate use

Clinical Trial: Efficacy and Safety of Peginterferon alfa-2a alone or in combination with Ribavirin in Patients with Chronic Hepatitis D
N° Sites: 1
N° Patients: 12
Trial Design: Phase IIIB

Clinical Trial: Efficacy of Peg-Interferon alfa-2-a and Ribavirin plus Metformina versus Peg-Interferon alfa2-a and Ribavirin for treatment of naive patients affected by Hepatitis chronic C (HCV) with resistence-insulin .Controlled randomized study. (MetViral study)
N° Sites: 15
N° Patients: 60
Trial Design: Phase IIIB

Clinical Trial: Clinical History of Hepatic failure: an observational, multicentric study (Epasco Study)
N° Sites: 24
N° Patients: 496
Trial Design: No-profit, epidemiologic

Clinical Trial: Observational study on metabolic and fat tissue alterations in non-naive HIV+ patients after variations of current anti-HIV treatment involving tenofovir (Osma Study)
N° Sites: 25
N° Patients: 454
Trial Design: Observational

Clinical Trial: Pharmacokinetics, pharmacodynamics and Viro-immunological state modifications in HIV+ patients treated with a bailout therapeutic scheme (Vipers Study)
N° Sites: 11
N° Patients: 7
Trial Design: Observational with kinetic and genomic analysis

Clinical Trial: Nash prevalence in an Italian population (Bagnacavallo)
N° Sites: 1
N° Patients: 11000
Trial Design: Population survey

Clinical Trial: HCV+ naive and never treated patients: analysis of reasons for not treating them (Mosaic study)
N° Sites: 25
N° Patients: 29
Trial Design: Observational and epidemiologic

Clinical Trial: Efficacy of automatic treatment in atrial unrhythmus. Randomized, open, parallel-arms, Study (Trade Study)
N° Sites: 21
N° Patients: 420
Trial Design: Phase IV - Randomized, device

Clinical Trial: Study about valuation DM: Pure Compliance A6
N° Sites: 40
N° Patients: 1250
Trial Design: Observational on device safety and usability

Clinical Trial: SITAF - Gise - Italian Registry
N° Sites: 40
N° Patients: 1250
Trial Design: Observational Multicentric, Cardiologic

Clinical Trial: Research on Hepatorenal syndrome (Epaser Study)
N° Sites: 30
N° Patients: 150
Trial Design: Observational and epidemiologic, no-profit

Clinical Trial: Efficacy of a solution for peritoneal dialysis of day-change with L-Carnitin on glicidic and lipidic metabolism, in patients with End Stage Renal Disease (ESRD) subjected to Peritoneal- Dialysis-Ambulatory Continues
N° Sites: 13
N° Patients: 120
Trial Design: Phase IIIB

Clinical Trial: Efficacy of a solution for peritoneal dialysis of day-change with L-Carnitin on glicidic metabolism, in type II diabetic-patients with End Stage Renal Disease (ESRD) subjected to Peritoneal- Dialysis-Ambulatory Continues
N° Sites: 12
N° Patients: 100
Trial Design: Phase IIIB

Clinical Trial: Study on bacterial resistance in patients with cirrhosis and infections (EpaInf Study)
N° Sites: 22
N° Patients: 180
Trial Design: Observational and epidemiologic, no-profit

Clinical Trial: Clinical study on efficacy and safety of Doxiciclina to prolong life in patients with Creuztfeld-Jacobs syndrome
N° Sites: 10
N° Patients: 60
Trial Design: Phase IIIB, AIFA supported

Clinical Trial: : A Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System as a revascularization treatment of patients with Multi-vessel Coronary Artery Disease (MVD-CAD): randomized study
N° Sites: 10
N° Patients: 250
Trial Design: Phase III, Multicentric, Randomized

Clinical Trial: Italian PFO (Patent Foramen Ovale ) Registry
N° Sites: 50
N° Patients: 1400
Trial Design: Observational, multicentric, cardiologic registry

Clinical Trial: A Clinical Evaluation of the XIENCE™ V Everolimus Eluting Coronary Stent System as a revascularization treatment of patients with Multi-vessel Coronary Artery Disease (MVD-CAD): open Registry
N° Sites: 17
N° Patients: 397
Trial Design: Observational multicentric registry

Clinical Trial: : Observational study in italian patients heart-transplanted, in treatment with immune-suppressive therapy in association with Everolimus
N° Sites: 12
N° Patients: 340
Trial Design: Observational and safety evaluation

Clinical Trial: Observational study in italian patients kidney-transplanted, in treatment with immune-suppressive therapy in association with Everolimus
N° Sites: 29
N° Patients: 360
Trial Design: Observational and safety evaluation

Clinical Trial: Zactima in NSCLC ELderly patients In combination with or versus Gemcitabine (Zelig Study)
N° Sites: 15
N° Patients: 180
Trial Design: Phase III, Multicentric, Randomized

Clinical Trial: Telbivudina and Interferon pegilated for treatment of patients HBV+ (Tel-B Peg Study)
N° Sites: 15
N° Patients: 350
Trial Design: Phase III, Multicentric, Randomized

Clinical Trial: Validation of systems HCC-stages, in patients with cirrhosis (EpaHCC Study)
N° Sites: 50
N° Patients: 283
Trial Design: Epidemiologic, Observational Multicentric Registry

Clinical Trial: Epidemiologic study in patients with Chronic Hepatitis due to different etiology (Epacron Study)
N° Sites: 25
N° Patients: 400
Trial Design: Epidemiologic, Observational Multicentric Registry

Clinical Trial: Comparison between frovatriptan plus different treatment regimens of dexketoprofen (25 mg and 37.5 mg) and frovatriptan alone in the acute treatment of migraine without aura and migraine with aura attacks
N° Sites: 12
N° Patients: 21
Trial Design: Observational multicentric registry

Clinical Trial: Multicentric Prospectic Study on DVT in shoulder orthopedic surgery
N° Sites: 15
N° Patients: 46
Trial Design: Observational multicentric registry

Clinical Trial: Italian Registry on Percutaneous Valvular substitution
N° Sites: 1
N° Patients: 6
Trial Design: Observational multicentric registry

Clinical Trial: A phase ii randomized, double-blind study vs. placebo for the evaluation of efficacy and tolerability of Salbutamol administered by oral route in patients affected by spinal muscular athrophy
N° Sites: 6
N° Patients: 1
Trial Design: Observational multicentric registry

Clinical Trial: Acromegalia Registry
N° Sites: 10
N° Patients: 158
Trial Design: Observational multicentric registry

Clinical Trial: Multicentric AISF study on HBV infections in patient with solid or hematologic cancer undegoing chemotherapy: infection prevalence, reactivation risk and reactivation prophilaxys
N° Sites: 40
N° Patients: 3
Trial Design: Epidemiological (1) and Phase III (2) Studies

Clinical Trial: : "Second Generation" Drug-Eluting Stents Implantation followed by Six versus Twelve-Month - Dual Antiplatelet Therapy
N° Sites: 11
N° Patients: 52
Trial Design: Multicentric Randomized Trial

Clinical Trial: Randomized Evaluation of Paclitaxel-eluted balloon for the treatment of de novo native coronary artery lesions
N° Sites: 3
N° Patients: 5
Trial Design: Multicentric Randomized Trial